Sept 25 (Reuters) – Merck and Daiichi Sankyo have voluntarily withdrawn their US application seeking accelerated approval for their experimental lung cancer therapy, the drugmakers said on Friday.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Maju Samuel)
Comments